Primary Device ID | 05060146291576 |
NIH Device Record Key | ea04ca45-7f3b-42e6-be44-41fb455ba438 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | Caphosol |
Version Model Number | 64 x 15 mL ampules aqueous solution |
Company DUNS | 220512050 |
Company Name | EUSA PHARMA (UK) LIMITED |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | true |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Device Issuing Agency | Device ID |
---|---|
GS1 | 05060146291576 [Primary] |
LFD | Saliva, Artificial |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | New |
Device Record Status | Published |
Public Version Number | 1 |
Public Version Date | 2024-04-04 |
Device Publish Date | 2024-03-27 |
05060146293129 - Caphosol® Artifical Saliva | 2024-07-04 Caphosol® is a preparation comprising two separately packaged aqueous solutions, a phosphate solution (Caphosol® A) and a calc |
05060146291576 - Caphosol | 2024-04-04Caphosol is a preparation comprising two separately packaged aqueous solutions, a phosphate solution (Caphosol A) and a calcium solution (Caphosol B) which when both ampule solutions are combined in equal volumes form a solution supersaturated with respect to both calcium and phosphate ions. |
05060146291576 - Caphosol | 2024-04-04 Caphosol is a preparation comprising two separately packaged aqueous solutions, a phosphate solution (Caphosol A) and a calcium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CAPHOSOL 75092944 2487745 Live/Registered |
EUSA PHARMA (USA), INC. 1996-04-23 |